- Drug Pipelines
- January 2022
- 30 Pages
Global
From €449EUR$500USD£383GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €449EUR$500USD£383GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €449EUR$500USD£383GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €449EUR$500USD£383GBP
- Report
- October 2023
- 146 Pages
Global
From €3727EUR$4,150USD£3,179GBP
- Report
- June 2025
Europe
From €3583EUR$3,990USD£3,056GBP
From €1881EUR$2,095USD£1,605GBP
€3583EUR$3,990USD£3,056GBP
- Report
- June 2025
United States
From €1881EUR$2,095USD£1,605GBP
€3583EUR$3,990USD£3,056GBP
- Report
- June 2025
North America
From €1881EUR$2,095USD£1,605GBP
€3583EUR$3,990USD£3,056GBP
- Report
- June 2025
Europe
From €1881EUR$2,095USD£1,605GBP
€3583EUR$3,990USD£3,056GBP
- Report
- June 2025
Middle East
From €1881EUR$2,095USD£1,605GBP
€3583EUR$3,990USD£3,056GBP
- Report
- June 2025
Asia Pacific
From €1881EUR$2,095USD£1,605GBP
€3583EUR$3,990USD£3,056GBP
- Report
- June 2025
Global
From €1881EUR$2,095USD£1,605GBP
€3583EUR$3,990USD£3,056GBP
- Report
- May 2025
- 91 Pages
Global
From €3500EUR$4,175USD£3,090GBP
- Report
- May 2025
- 82 Pages
Global
From €3500EUR$4,175USD£3,090GBP
- Report
- March 2025
- 103 Pages
Global
From €3500EUR$4,175USD£3,090GBP
- Report
- March 2025
- 104 Pages
Global
From €3500EUR$4,175USD£3,090GBP
- Report
- January 2025
- 80 Pages
Global
From €3500EUR$4,175USD£3,090GBP
- Report
- January 2025
- 81 Pages
Global
From €3500EUR$4,175USD£3,090GBP
- Report
- January 2025
- 135 Pages
Global
From €3500EUR$4,175USD£3,090GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more